Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes

Annals of Medicine

Volumn 40, Issue 8, 2008, Pages 627-633

  Gordin, Daniel ^a,b   Forsblom, Carol ^a,b   Rönnback, Mats ^a,b   Parkkonen, Maija ^a,b   Wadén, Johan ^a,b   Hietala, Kustaa ^a,b   Groop, Per Henrik ^a,b,c  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Acute hyperglycaemia; Cardiovascular disease; Inflammation; Macrovascular disease; Oxidative stress; Type 1 diabetes

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 56849120612     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890802126547     Document Type: Article

References (43)

1. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol. 1987;59:750-5.
2. Dorman JS, Laporte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study: mortality results. Diabetes. 1984;33:271-6.
3. The effect of intensive treatment of diabetes on the development and progression of the long-term complications of insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-86.
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643-53.
5. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-26.
6. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
7. Kampus P, Kals J, Ristimae T, Muda P, Ulst P, Zilmer K, et al. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein. J Hypertens. 2007;25:819-25.
8. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24:969-74.
9. Criuickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance. Circulation. 2002;106:2085-90.
10. Stefanadis C, Dernellis J, Tsiamis E, Diamantopoulos L, Michaelides A, Toutouzas P. Assessment of aortic line of elasticity using nonlinear regression analysis. Circulation. 2000;101:1819-25.
11. Gordin D, Rönnback M, Forsblom C, Heikkilä O, Saraheimo M, Groop P-H. Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia. 2007;50:516-22.
12. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycaemia in humans. Role of oxidative stress. Circulation. 2003;107:206-7.
13. Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D. Acute hyperglycaemia induces an oxidative stress in healthy subjects. J Clin Invest. 2001;108:635-6.
14. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, et al. Acute hyperglycaemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002;51:1076-82.
15. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, et al. Vascular effects of acute hyperglycaemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycaemia. Circulation. 1997;95:1783-90.
16. Marfella R, Esposito K, Giunta R, Coppola G, De Angelis L, Farzati B, et al. Circulating adhesion molecules in humans: role of hyperglycaemia and hyperinsulinemia. Circulation. 2000;101:2247-51.
17. Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, et al. FinnDiane Study Group. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the Finn-Diane study). Diabetes Care. 2005;28:2019-24.
18. Gordin D, Forsblom C, Rönnback M, Groop PH. Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes. Diabet Med. 2008;25:101-5.
19. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19:972-8.
20. Morohoshi M, Fujisawa K, Uchimura I, Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes. 1996;45:954-9.
21. Morohoshi M, Fujisawa K, Uchimura I, Numano F. The effect of glucose and advanced end products on IL-6 production by human monocytes. Ann N Y Acad Sci. 1995;748:562-70.
22. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.
23. Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart. 2002;87:201-4.
24. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003;169:203-14.
25. Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia. 2003;46:1402-7.
26. Davï G, Chiarelli F, Santilli F, Pomilio M, Vigneri S, Falco A, et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation. 2003;107:3199-203.
27. Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care. 2003;26:2165-73.
28. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995;96:1395-403.
29. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theory versus practice. Circulation. 1999;100:1148-50.
30. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke. 2002;33:31-7.
31. Karalis K, Mastorakos G, Chrousos GP, Tolis G. Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest. 1994;93:2000-6.
32. Lang A, Sakhnini E, Fidder HH, Maor Y, Bar-Meir S, Chowers Y. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int. 2005;25:808-16.
33. Petersen AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol. 2006;57:43-51.
34. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund PB. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000;529:237-42.
35. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994-9.
36. González-Clemente JM, Giménez-Pérez G, Richart C, Broch M, Caixàs A, Megia A, et al. The tumour necrosis factor (TNF)-alpha system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus. Eur J Endocrinol. 2005;153:687-91.
37. McEniery CM, Wilkinson IB. Large artery stiffness and inflammation. J Hum Hypertens. 2005;19:507-9.
38. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-20.
39. Beckman JA, Goldfine AB, Gordon MB, Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycaemia in humans. Circulation. 2001;103:1618-23.
40. Elhadd TA, Kennedy G, Hill A, McLaren M, Newton RW, Greene SA, et al. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metab Res Rev. 1999;15:405-11.
41. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med. 1997;14:S45-9.
42. Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988;81:442-8.
43. Westerbacka J, Wilkinson I, Cockcroft J, Utriainen T, Vehkavaara S, Yki-Järvinen H. Diminished wave reflection in the aorta. A novel physiological action of insulin on large blood vessels. Hypertension. 1999;33:1118-22.